[go: up one dir, main page]

ITMI20041962A1 - "peptide di angiostatina e suoi impieghio terapeutici" - Google Patents

"peptide di angiostatina e suoi impieghio terapeutici"

Info

Publication number
ITMI20041962A1
ITMI20041962A1 IT001962A ITMI20041962A ITMI20041962A1 IT MI20041962 A1 ITMI20041962 A1 IT MI20041962A1 IT 001962 A IT001962 A IT 001962A IT MI20041962 A ITMI20041962 A IT MI20041962A IT MI20041962 A1 ITMI20041962 A1 IT MI20041962A1
Authority
IT
Italy
Prior art keywords
angiostatin
employees
peptide
therapeutic
therapeutic employees
Prior art date
Application number
IT001962A
Other languages
English (en)
Inventor
Adriana Albini
Roberto Benelli
Claudio Brigati
Eva Raffaella Dell
Simona Minghelli
Monica Morini
Douglas M Noonan
Original Assignee
Istituto Naz Per La Ricerca S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Naz Per La Ricerca S filed Critical Istituto Naz Per La Ricerca S
Priority to IT001962A priority Critical patent/ITMI20041962A1/it
Publication of ITMI20041962A1 publication Critical patent/ITMI20041962A1/it
Priority to JP2007536093A priority patent/JP2008516910A/ja
Priority to EP05799568A priority patent/EP1799716A1/en
Priority to PCT/EP2005/011022 priority patent/WO2006040157A1/en
Priority to US11/577,202 priority patent/US20110144022A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT001962A 2004-10-15 2004-10-15 "peptide di angiostatina e suoi impieghio terapeutici" ITMI20041962A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT001962A ITMI20041962A1 (it) 2004-10-15 2004-10-15 "peptide di angiostatina e suoi impieghio terapeutici"
JP2007536093A JP2008516910A (ja) 2004-10-15 2005-10-13 抗血管新生ペプチド
EP05799568A EP1799716A1 (en) 2004-10-15 2005-10-13 Anti-angiogenic peptide
PCT/EP2005/011022 WO2006040157A1 (en) 2004-10-15 2005-10-13 Anti-angiogenic peptide
US11/577,202 US20110144022A1 (en) 2004-10-15 2005-10-13 Anti-Angiogenic Peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001962A ITMI20041962A1 (it) 2004-10-15 2004-10-15 "peptide di angiostatina e suoi impieghio terapeutici"

Publications (1)

Publication Number Publication Date
ITMI20041962A1 true ITMI20041962A1 (it) 2005-01-15

Family

ID=35695773

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001962A ITMI20041962A1 (it) 2004-10-15 2004-10-15 "peptide di angiostatina e suoi impieghio terapeutici"

Country Status (5)

Country Link
US (1) US20110144022A1 (it)
EP (1) EP1799716A1 (it)
JP (1) JP2008516910A (it)
IT (1) ITMI20041962A1 (it)
WO (1) WO2006040157A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20060625A1 (it) * 2006-03-31 2007-10-01 Istituto Naz Per La Ricerca Peptide antiangiogenico e suoi impieghi terapeutici
EP2044951A1 (en) * 2007-10-02 2009-04-08 Merz Pharma GmbH & Co. KGaA The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
US9169294B2 (en) 2013-03-11 2015-10-27 Northwestern University Anti-angiogenic molecules, nanostructures and uses thereof
IT202100023357A1 (it) 2021-09-09 2023-03-09 Cheirontech S R L Peptidi con attività anti-angiogenica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837682A (en) * 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
CN1195375A (zh) * 1995-04-26 1998-10-07 儿童医学中心公司 血管抑制素片段和集合血管抑制素及其使用方法

Also Published As

Publication number Publication date
JP2008516910A (ja) 2008-05-22
EP1799716A1 (en) 2007-06-27
US20110144022A1 (en) 2011-06-16
WO2006040157A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
HK1201539A1 (zh) 異源多肽及其治療用途
EP1740197A4 (en) ENZYME-BASED THERAPEUTIC PREPARATION AND USES THEREOF
CY2016035I2 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
EP1838331A4 (en) ANTIMICROBIAL PEPTIDES AND METHOD OF USE
EP1827289A4 (en) IMPLANT AND IMPLANT ELEMENT
ATE486091T1 (de) Vegf-fallen und therapeutische verwendungen dafür
EP1732581A4 (en) POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES
EP1711207A4 (en) INTERFERON ALPHA ANTIBODIES AND ITS USES
DK1513873T3 (da) Terapeutiske epitoper og anvendelser deraf
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
DK1824775T3 (da) Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf
NO20044916L (no) Preparater av sulfinylacetamid
DK1663291T3 (da) Rekombinante lubricinmolekyler og anvendelser deraf
EP1794589A4 (en) PROTEIN ARRAYS AND METHOD OF USE THEREOF
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EP1727065A4 (en) Event sequencer
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
HK1109581A1 (en) Pharmaceutical use of graptopetalum and related plants
DK1667693T3 (da) Præparater og fremgangsmåder til anvendelse af lamellare bodies til terapeutiske formål
ITTO20040211A1 (it) Macchina frantumatrice di pietrisco e affini
EP1834257A4 (en) SPATIAL SEARCH AND SELECTION FEATURE
IL179555A0 (en) Indentification of ergothioneine transporter and therapeutic uses thereof
ITMI20041962A1 (it) "peptide di angiostatina e suoi impieghio terapeutici"